Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Adverse drug reactions 

Cardiovascular drugs unlikely to worsen erectile dysfunction

A study of more than 2,000 men has shown that antihypertensive and statin use has a neutral effect on erectile dysfunction.

Heart disease, x-ray showing enlarged heart

Source: Alain Pol, ISM / Science Photo Library

Researchers say worsening erectile dysfunction should not be a reason for men at risk of cardiovascular disease to discontinue taking antihypertensives and statins

Erectile dysfunction (ED) is associated with cardiovascular disease (CVD) but it is unclear whether medications to treat CVD worsen ED symptoms.

To explore this, researchers analysed data on International Index of Erectile Function (IIEF) erectile function domain scores from a trial in which men with at least one cardiovascular risk factor were randomly assigned to antihypertensive treatment (fixed-dose candesartan 16mg and hydrochlorothiazide 12.5mg) or placebo, and rosuvastatin 10mg or placebo.

Over a mean follow-up of 5.8 years in 2,153 men, the researchers found no significant difference in the mean IIEF score change from baseline with either antihypertensive or statin treatment alone versus placebo, nor between antihypertensive and statin treatment versus double placebo.

Writing in the Canadian Journal of Cardiology (January 2018), the researchers said the findings indicate that antihypertensive and statin use has a neutral effect on symptoms of ED, and worsening ED should not be a reason for men at risk of CVD to discontinue these treatments[1].

Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20204465

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Clinical Pharmacokinetics

    Clinical Pharmacokinetics

    A practical guide to the use of pharmacokinetic principles in clinical practice. Includes case studies with questions and answers.

    £33.00Buy now
  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Strategic Medicines Management

    Strategic Medicines Management

    A practical guide to influencing the availability of medicines, and policies of their use. Focuses on the strategic elements of medicines management.

    £33.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Heart disease, x-ray showing enlarged heart

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.